Serum total and high-density lipoprotein phospholipids: Independent predictive value for cardiometabolic risk

Onat A., Cakmak H. A. , Can G. , Yuksel M., KOROGLU B., Yuksel H.

CLINICAL NUTRITION, vol.33, no.5, pp.815-822, 2014 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 33 Issue: 5
  • Publication Date: 2014
  • Doi Number: 10.1016/j.clnu.2013.10.020
  • Title of Journal : CLINICAL NUTRITION
  • Page Numbers: pp.815-822
  • Keywords: Apolipoprotein A-I, Coronary heart disease risk, HDL-cholesterol, Metabolic syndrome, Phospholipids, Population-based study, METABOLIC SYNDROME, OXIDIZED PHOSPHOLIPIDS, HDL, ACID, ATHEROGENESIS, INFLAMMATION, DYSFUNCTION


Objective: Given that serum phospholipids (PL) may serve as inflammation mediators, we studied whether they predicted metabolic syndrome (MetS), type-2 diabetes or coronary heart disease (CHD) risk in people prone to enhanced low-grade inflammation.